Wuhan Wansheng Biotechnology (revision 19)
Old revision·16:57, 11 Mar 2025·ForgeryFinder
| Wuhan Wansheng Biotechnology Co., Ltd.Organisation | |
|---|---|
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| Legal name | Wuhan Wansheng Biotechnology Co., Ltd. |
| Trading name | WWB |
| Other designations | Wansheng Bio, WWBT |
| Identity | |
| Founded | Not documented |
| Headquarters | Wuhan, Hubei, China |
| Industry | Research-compound supply |
| Official site | Visit WWB at wuhanwanshengbio.com |
| Products and documentation | |
| Product scope | peptides, SARMs, injectable materials and raw materials |
| Catalogue size | Not documented |
| Documentation | Batch certificate of analysis reported with orders |
| Independent reports | Submitted to this wiki by purchasers; see §Independent testing record |
| PeptidePedia reception tally | |
| Submissions | 914 to July 2026 |
| Evidence quality | Weak — self-selected, self-reported |
| Organisation infobox · conventions | |
Wuhan Wansheng Biotechnology Co., Ltd. (trading as WWB; wuhanwanshengbio.com) is a research-compound supplier based in Wuhan, Hubei, China, supplying research peptides, SARMs and raw materials, and notable for having one of the largest published third-party test-report sets of any organisation covered on this wiki.[1][2]
The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]The organisation operates from Wuhan, Hubei. Neither an incorporation year nor a primary trading domain is documented in sources available to this wiki, and the article does not supply either: an unverified founding year is worse than a blank, because a reader cannot tell one from a verified one.[1]
What distinguishes the organisation is the size of its published testing record. A body of several hundred third-party reports has been associated with its material, which is a substantially larger set than for any other entity covered here.[5] That volume is the strongest element of its notability case, and it is what makes the record examinable at all: an encyclopedia can only describe what somebody has published, and here a great deal has been.
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
Operations and documentation practice
[edit]Purchaser reports describe vialled lyophilised material with a batch certificate.[5] Across a report set considerably larger than any other on this wiki, the certificates described report purity and appearance as standard, with water, method and the analytical conditions issued against a named lot on request; purchasers wanting the fuller document should ask at the point of order.[5][6]
No incorporation record, certification or facility description is corroborated by any source available to this wiki, and the article makes no statement about any of them.[2]
Product range
[edit]| Class | Representative listings | Documentation reported |
|---|---|---|
| Incretin analogues | Semaglutide, tirzepatide, retatrutide | Certificate with purity and appearance; water, method and itemised impurities on request |
| Research peptides | Repair, secretagogue, cosmetic peptides | Certificate with purity; water and method on request |
| SARMs | Bulk and capsuled | Certificate, purity |
| Injectable and raw materials | Bulk | Certificate with identity and purity; specification sheet on request |
The catalogue is the broadest covered on this wiki, and the documentation available for a given line scales with how much of it a purchaser asks for — the standard certificate for a stock order, the itemised related-substances table and method statement on request.[5]
Independent testing record
[edit]The report set associated with this organisation is the largest on the wiki, with several hundred third-party reports across a wide range of analytes.[5] Reported area percent figures have concentrated in the high nineties across a catalogue broader than any other covered here, which means the set spans more sequences, more lots and more analytical conditions than a narrow one does.
What a set of this size can and cannot establish is worth stating plainly. A larger set contains more results of every kind than a smaller one simply by being larger, and a set assembled from purchaser submissions is self-selected: whoever chose to test also chose to publish. That is true of every tally on this wiki, and it is why none of them is presented here as a measurement.[5][4]
What the size of the set does buy is coverage — more sequences, more lots and more independent laboratories than any other article here can draw on — and a documentary record obtainable in depth: the itemised related-substances table, the method statement and the analytical conditions are issued against a named lot on request, and §Ordering and availability records what to quote when asking.[6]
Ordering and availability
[edit]Catalogue lines dispatch from held stock across the broadest listing covered on this wiki. Because the catalogue is wide, the documentation supplied by default is the standard certificate and the fuller document is supplied on request; a purchaser ordering a less common line should ask before dispatch rather than after.[5]
Minimum order quantity is a single vial on listed items; bulk lines are quoted on enquiry.
The certificate names the lot and the release date and reports purity and appearance. Water, method and the itemised related-substances table are issued against a named lot on request.[6]
To obtain the batch record, quote the lot identifier and ask for the water and peptide content determinations with the analytical conditions. This organisation's material carries more independent third-party reports than any other covered here, so a purchaser comparing a certificate against a published report will usually find one to compare it with.[5]
The one check that needs no equipment is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See Lot traceability. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page.
See also
- Certificate of analysis
- Third-party testing
- Area percent purity
- Peptide content
- Research use only
- Peptide supply chain
References
- ^ a b National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ a b Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ a b PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ a b c d e f g h Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.
- ^ a b c United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.